Is there any condition that can link tightening in the right neck, elevated serum iron, elevated mean platelet volume, low mean corpuscular hemoglobin concentration, and new‑onset bradycardia?

Haemochromatosis (Iron Overload) Can Link These Findings

The combination of elevated serum iron (178 mg/dL), new-onset bradycardia, and neck tightness should prompt immediate evaluation for haemochromatosis with cardiac involvement, as iron deposition in the cardiac conduction system—particularly the atrioventricular node—can cause extreme bradycardia and potentially life-threatening arrhythmias. 111

Why Haemochromatosis Explains This Constellation

The 2022 EASL Clinical Practice Guidelines on Haemochromatosis explicitly describe this clinical picture 11:

• Cardiac iron deposition causes conduction disturbances including extreme bradycardia, heart blocks, and sudden death—even in the absence of heart failure
• Myocardial iron accumulation can involve the conduction system, especially the atrioventricular node
• These cardiac manifestations occur in severe haemochromatosis (particularly juvenile forms, but also in advanced adult disease)

The Laboratory Findings Fit

Elevated iron (178 mg/dL): This is the hallmark of haemochromatosis and directly reflects iron overload 11.

Low MCHC (30.8 g/dL): This appears paradoxical but requires careful interpretation. The guidelines note that haemochromatosis typically shows increased MCHC, MCV, and MCH due to abundant iron for erythropoiesis 11. Your low MCHC suggests either:

• Concurrent iron deficiency (which would be unusual but possible with bleeding)
• Laboratory artifact or measurement timing issue
• A mixed picture requiring further investigation

Elevated MPV (13.1 fL): Research demonstrates that iron status significantly affects platelet parameters 234. However, the relationship is complex:

• Iron deficiency typically causes elevated MPV and thrombocytosis 23
• Iron overload (haemochromatosis) shows the opposite pattern
• Your elevated MPV conflicts with elevated iron, suggesting either a concurrent process or reactive changes

The Neck Tightness Connection

While neck tightness is not a classic haemochromatosis symptom, consider:

• Cardiac origin: Bradycardia with inadequate cardiac output can cause neck discomfort or vascular sensations
• Musculoskeletal: Haemochromatosis causes severe arthropathy affecting multiple joints 1, though neck involvement is less typical
• Unrelated: May represent a separate cervical spine or muscular issue

Immediate Diagnostic Workup Required

You must urgently evaluate for cardiac iron overload 11:

1. ECG and Holter monitoring - Document bradycardia type, assess for heart blocks
2. Transthoracic echocardiography - Evaluate for cardiomyopathy
3. Cardiac MRI with R2* - Quantify myocardial iron deposition (gold standard) 11
4. Complete iron panel:
   • Serum ferritin (critical prognostic marker)
   • Transferrin saturation
   • Total iron-binding capacity
5. HFE genetic testing - Screen for C282Y and H63D mutations
6. Hepatic MRI R2* - Quantify liver iron concentration 1

Critical Caveat About Bradycardia

The bradycardia in haemochromatosis can be "extreme" and may necessitate pacemaker implantation 11. This is not benign—it represents significant cardiac iron deposition and carries risk of sudden death. A case report from 1991 documented a young man with haemochromatosis presenting specifically with palpitations and bradycardia alternating with tachycardia 5.

The Discordant Laboratory Values

The conflicting findings (elevated iron with low MCHC and high MPV) suggest:

1. Mixed iron disorder: Possible chronic blood loss causing iron deficiency despite underlying haemochromatosis (paradoxical but documented)
2. Laboratory timing: Recent phlebotomy, blood donation, or menstrual loss could temporarily lower MCHC
3. Concurrent condition: Thalassemia trait, chronic disease, or other hemoglobinopathy

You must obtain a complete CBC with reticulocyte count, peripheral blood smear, and reticulocyte hemoglobin equivalent (Ret-He) to clarify the iron status 67.

Treatment Implications

If haemochromatosis with cardiac involvement is confirmed:

• Phlebotomy remains first-line for iron removal 11
• Cardiac monitoring is mandatory during treatment
• Iron chelation therapy (deferasirox) may be needed if cardiac instability precludes phlebotomy 11
• Pacemaker consideration if bradycardia is symptomatic or severe 11

Prognosis Warning

Untreated cardiac haemochromatosis can lead to severe heart failure before age 30, death, or need for heart transplant 1. Early iron removal can prevent, improve, or even reverse cardiac dysfunction 1, making urgent diagnosis critical for mortality and quality of life outcomes.

Alternative Considerations

While haemochromatosis best explains the elevated iron and bradycardia, also consider:

• Hypothyroidism - Can cause bradycardia and altered iron metabolism (check TSH)
• Athletic heart syndrome - Physiologic bradycardia in athletes (but wouldn't explain iron elevation)
• Medications - Beta-blockers, calcium channel blockers, digoxin (review medication list)
• Infiltrative cardiomyopathy - Sarcoidosis, amyloidosis (less likely with isolated iron elevation)

The elevated iron of 178 mg/dL is the key finding that points toward haemochromatosis as the unifying diagnosis, particularly when combined with new-onset bradycardia in the context of potential cardiac iron deposition 115.